What are the key questions for Cancer Associated Thrombosis?
Patients with cancer are 4-7x more likely to develop a venous thromboembolism (VTE) than the general population, and up to 20% of patients with cancer will develop a VTE. Moreover, Cancer-Associated Thrombosis (CAT) is one of the leading causes of death in cancer patients. Therefore, it’s important for clinicians to have a clear understanding of the factors that put patients with cancer at an increased risk of CAT. In the video provided below, Dr Mari Thomas addresses the question ‘which patients with cancer are most at risk of developing a VTE?’.
Dr Mari Thomas “If you've got cancer, then you're about five to seven times more likely to have a blood clot than patients who don't have cancer.”
Xarelto (rivaroxaban) Prescribing information
Presented by: Dr Mari Thomas, Consultant Haematologist, University College London Hospitals
Watch Dr Mari Thomas as she addresses a number of other key questions on the topic of Cancer Associated Thrombosis in the videos below
Footnotes
CAT, Cancer Associated Thrombosis; VTE, Venous thromboembolism
RP-XAR-GB-5149 | February 2024